BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 30340558)

  • 1. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
    Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
    BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells.
    Yu Y; Zhang M; Zhang X; Cai Q; Hong S; Jiang W; Xu C
    J Hematol Oncol; 2014 May; 7():39. PubMed ID: 24886678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor.
    Dupré DJ; Thompson C; Chen Z; Rollin S; Larrivée JF; Le Gouill C; Rola-Pleszczynski M; Stanková J
    Cell Signal; 2007 Oct; 19(10):2068-79. PubMed ID: 17609120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.
    Deuster E; Hysenaj I; Kahaly M; Schmoeckel E; Mayr D; Beyer S; Kolben T; Hester A; Kraus F; Chelariu-Raicu A; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells.
    Bae R; Arteaga A; Raj JU; Ibe BO
    Int Arch Allergy Immunol; 2012; 158(1):18-26. PubMed ID: 22212397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.
    Yu Y; Zhang X; Hong S; Zhang M; Cai Q; Zhang M; Jiang W; Xu C
    Br J Cancer; 2014 Jul; 111(3):515-24. PubMed ID: 24921917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
    Sahu RP
    Mol Med Rep; 2015 Jul; 12(1):394-400. PubMed ID: 25695262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells.
    Yu Y; Zhang M; Zhang X; Cai Q; Zhu Z; Jiang W; Xu C
    J Exp Clin Cancer Res; 2014 Sep; 33(1):85. PubMed ID: 25261977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
    Aponte M; Jiang W; Lakkis M; Li MJ; Edwards D; Albitar L; Vitonis A; Mok SC; Cramer DW; Ye B
    Cancer Res; 2008 Jul; 68(14):5839-48. PubMed ID: 18632638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
    Jiang W; Wang YS; Cong Q; Li MJ; Ye B; Xu CJ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):931-5. PubMed ID: 22333285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor induces the stemness of ovarian cancer cells via the PAF/PAFR signaling pathway.
    Gao T; Zhao R; Yao L; Xu C; Cong Q; Jiang W
    Am J Transl Res; 2020; 12(11):7249-7261. PubMed ID: 33312364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma.
    Onuchic AC; Machado CM; Saito RF; Rios FJ; Jancar S; Chammas R
    Mediators Inflamm; 2012; 2012():175408. PubMed ID: 22570511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
    Lukashova V; Chen Z; Duhé RJ; Rola-Pleszczynski M; Stanková J
    J Immunol; 2003 Oct; 171(7):3794-800. PubMed ID: 14500680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
    Souza DG; Pinho V; Soares AC; Shimizu T; Ishii S; Teixeira MM
    Br J Pharmacol; 2003 Jun; 139(4):733-40. PubMed ID: 12812996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes.
    Shimada A; Ota Y; Sugiyama Y; Sato S; Kume K; Shimizu T; Inoue S
    J Invest Dermatol; 1998 Jun; 110(6):889-93. PubMed ID: 9620295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smoke.
    Shukla SD; Fairbairn RL; Gell DA; Latham RD; Sohal SS; Walters EH; O'Toole RF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1647-55. PubMed ID: 27524890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.
    Dyer KD; Percopo CM; Xie Z; Yang Z; Kim JD; Davoine F; Lacy P; Druey KM; Moqbel R; Rosenberg HF
    J Immunol; 2010 Jun; 184(11):6327-34. PubMed ID: 20421642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.
    de Oliveira SI; Andrade LN; Onuchic AC; Nonogaki S; Fernandes PD; Pinheiro MC; Rohde CB; Chammas R; Jancar S
    BMC Cancer; 2010 May; 10():200. PubMed ID: 20465821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
    Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
    Melnikova VO; Mourad-Zeidan AA; Lev DC; Bar-Eli M
    J Biol Chem; 2006 Feb; 281(5):2911-22. PubMed ID: 16306050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.